Alpha-synuclein preformed fibrils: a tool to understand Parkinson's disease and develop disease modifying therapy
Piotr Chmielarz1
Andrii Domanskyi2
1.Institute of Biotechnology, HiLIFE, University of Helsinki, Finland;Maj Institute of Pharmacology, Polish Academy of Sciences, Department of Brain Biochemistry, Kraków, Poland2.Institute of Biotechnology, HiLIFE, University of Helsinki, Finland;Orion Corporation Orion Pharma, Turku, Finland
摘要：Parkinson's disease (PD) is the second most common neurodegenerative disorder characterized by multiple motor and non-motor symptoms, which include, among others, constipation, sleep disturbance, bradykinesia, gait and balance abnormalities, muscle stiffness and resting tremor.
机标关键词：
论文发表日期：2021-11-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：3( 2219-2221 )